The Integration of Cell Therapy and Biomaterials as Treatment Strategies for Remyelination

The Integration of Cell Therapy and Biomaterials as Treatment Strategies for Remyelination

Multiple sclerosis (MS) is a chronic degenerative autoimmune disease of the central nervous system that causes inflammation, demyelinating lesions, and axonal damage and is associated with a high rate of early-onset disability. Disease-modifying therapies are used to mitigate the inflammatory proces...

Full description

Bibliographic Details
Main Authors: Eneritz López-Muguruza, Natalia Villar-Gómez, Jordi A. Matias-Guiu, Belen Selma-Calvo, Lidia Moreno-Jiménez, Francisco Sancho-Bielsa, Juan Lopez-Carbonero, María Soledad Benito-Martín, Silvia García-Flores, Natalia Bonel-García, Ola Mohamed-Fathy Kamal, Denise Ojeda-Hernández, Jorge Matías-Guiu, Ulises Gómez-Pinedo
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Life
Subjects:
Multiple sclerosis
remyelination
cell therapy
biomaterials
Online Access:https://www.mdpi.com/2075-1729/12/4/474

Internet

https://www.mdpi.com/2075-1729/12/4/474

Similar Items